Tandem Diabetes Care | TNDM - Ordinary Share Capital


Tandem Diabetes Care reported $67.77M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Abbott USD 1.74B 23.39B Sep/2025
Align Technology USD 72.49M 0 Sep/2025
AtriCure USD 49.7M 10K Sep/2025
Baxter International USD 683M 0 Dec/2024
Becton, Dickinson and Co. USD 286.63M 84.37M Sep/2025
Boston Scientific USD 1.48B 1.46B Jun/2025
Cooper Companies USD 198.81M 9K Sep/2025
Dexcom USD 392.2M 391.8M Jun/2025
Edwards Lifesciences USD 587.9M 66.9M Jun/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Globus Medical USD 135.05M 134.92M Jun/2025
ICU Medical USD 24.68M 22.22M Jun/2025
Insulet USD 70.35M 70.25M Sep/2025
Integra LifeSciences USD 77.92M 77M Jun/2025
Intuitive Surgical USD 354.5M 3.98M Dec/2025
J&J USD 2.41B 584K Sep/2025
Masimo USD 53.1M 1.2M Sep/2025
Medtronic USD 1.28B 66K Jun/2025
Merit Medical Systems USD 59.29M 72K Sep/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
Stryker USD 382.4M 93K Dec/2025
Tandem Diabetes Care USD 67.77M 242K Sep/2025
Teleflex USD 44.19M 482K Jun/2025
Zimmer Biomet Holdings USD 198.2M 195M Sep/2025